Equels Thomas K bought AIM
November 21, 2024 · Form 4 insider transaction
Equels Thomas K bought 20,000 shares of AIM ImmunoTech Inc. at $0.21 per share, a transaction worth $4.2K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 61 days after the transaction.
Direction
Acquired (buy-side)
Shares
20,000
Price
$0.21
Total value
$4.2K
InsiderEquels Thomas K
Role—
CompanyAIM ImmunoTech Inc. (AIM)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateNovember 21, 2024
Filing dateJanuary 21, 2025
Shares owned after1,657,968
OwnershipDirect
10b5-1 planNo
AmendedNo